High haemoglobin / haematocrit
Definition/Description
Investigation is suggested if the haematocrit is persistently (>2 months, preferably repeated without tourniquet) >0.52 (male) or >0.48 (female). This may be due to increased red cell mass (true polycythaemia) or reduced plasma volume (apparent polycythaemia). If the haematocrit is >0.6 (male) or >0.56 (female) then it can be assumed that there is a true increase in red cell mass.
Red Flag Symptoms
None provided
Guidelines on Management
Differential Diagnosis:
- Apparent polycythaemia may be due to a variety of causes such as diuretics, heavy smoking or alcohol, dehydration, stress, oedema, hypertension or obesity.
- True polycythaemia
- Reactive to hypoxia - e.g. pulmonary disease, carbon monoxide / heavy smoking, sleep apnoea or congenital cyanotic heart disease.
- Abnormal high erythropoietin - e.g. secondary to various tumours (e.g. renal carcinoma or hepatoma), renal transplant or renal artery stenosis.
- Polycythaemia vera - bone marrow disorder with uncontrolled red cell proliferation. Usually positive for JAK2 V617F mutation. Associated with thrombotic and haemorrhagic complications. May be associated with generalised itch (classically after a hot shower or bath), splenomegaly or raised WCC / PLT.
- Endocrine - Cushing's syndrome, Conn's syndrome, phaecochromocytoma or androgens (including testosterone supplements and anabolic steroids).
- Inherited erythropoietin or haemoglobin variants (rare).
Examination:
- Features of cardiac or pulmonary disease.
- Features of hyperviscosity (fatigue, headache, slowed thought, muscosal / retinal bleeding, blurred / double vision, chest / abdominal pain, myalgia).
- Splenomegaly suggests polycythaemia vera, although this is not consistent.
Baseline investigations:
- FBC, U+E, LFT, ferritin (a high haematocrit despite low ferritin strongly suggests polycythaemia vera. DO NOT give iron replacement).
- Review cardiovascular risk factors, although primary aspirin prophylaxis is not recommended unless PRV.
- Further tests as indicated by history, e.g. oxygen saturations, PFT, CXR.
Referral Criteria/Information
Referral:
- Review cardiovascular risk factors for all patients, regardless of cause.
- Haematocrit persistently >0.52 (male) or >0.48 (female) without obvious cause or with suspicion of polycythaemia vera. URGENT referral if features of hyperviscosity.
- Other referrals as directed by suspected cause, e.g. may benefit from long-term oxygen therapy or ACE-inhibitors if chronic hypoxia.
Additional Resources & Reference
Haematology Handbook - South Tees Hospitals NHS Foundation Trust
References:
McMullin MF, et al. A guideline for the investigation and management of polycythaemia vera. Br J Haematol 2018; doi.org/10.1111/bjh.15648
NICE Clinical Knowledge Summary. Polycythaemia / Erythrocytosis (September 2024). https://cks.nice.org.uk/polycythaemiaerythrocytosis
Associated Policies
There are no associated policies.
Specialties
Places covered by
- North Yorkshire
Hospital Trusts
South Tees Hospitals
Date created: 10/03/2026, 12:40
Last modified: 10/03/2026, 13:58
Date due for review: 01/02/2027